PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för antalarmin. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

16 hits

Bibliografisk träff 2014-01-17

Evidence of lasting dysregulation of neuroendocrine and HPA axis function following global cerebral ischemia in male rats and the effect of Antalarmin on plasma corticosterone level.

de la Tremblaye PB, Raymond J, Milot MR, Merali Z, Plamondon H.

Horm Behav · research support, non-u.s. gov't; journal article · DOI 10.1016/j.yhbeh.2014.01.003

Bibliografisk träff 2013-07-13

Coping with chronic social stress in mice: hypothalamic-pituitary-adrenal/ sympathetic-adrenal-medullary axis activity, behavioral changes and effects of antalarmin treatment: implications for the study of stress-related psychopathologies.

Pérez-Tejada J, Arregi A, Gómez-Lázaro E, Vegas O, Azpiroz A, Garmendia L.

Neuroendocrinology · research support, non-u.s. gov't; journal article · DOI 10.1159/000353620

Bibliografisk träff 2012-12-04

The effect of CRH and its inhibitor, antalarmin, on in vitro growth of preantral mouse follicles, early embryo development, and steroidogenesis.

Dinopoulou V, Partsinevelos GA, Mavrogianni D, Anagnostou E, Drakakis P, Makrigiannakis A, Chrousos GP, Loutradis D.

Endocrinology · journal article · DOI 10.1210/en.2012-1838

Bibliografisk träff 2009-06-30

Effects of antalarmin and nadolol on the relationship between social stress and pulmonary metastasis development in male OF1 mice.

Vegas O, Garmendia L, Arregi A, Beitia G, Azpiroz A.

Behav Brain Res · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bbr.2009.06.033

Bibliografisk träff 2009-01-01

Preformulation and pharmacokinetic studies on antalarmin: a novel stress inhibitor.

Sanghvi R, Mogalian E, Machatha SG, Narazaki R, Karlage KL, Jain P, Tabibi SE, Glaze E, Myrdal PB, Yalkowsky SH.

J Pharm Sci · comparative study; journal article · DOI 10.1002/jps.21421

Bibliografisk träff 2008-10-02

Effects of antalarmin, a CRF receptor 1 antagonist, on fright reaction and endocrine stress response in crucian carp (Carassius carassius).

Lastein S, Höglund E, Overli O, Døving KB.

J Comp Physiol A Neuroethol Sens Neural Behav Physiol · research support, non-u.s. gov't; journal article · DOI 10.1007/s00359-008-0372-9

Bibliografisk träff 2008-07-31

Antalarmin.

Slauson SR, Rimoldi JM, Fronczek FR.

Acta Crystallogr Sect E Struct Rep Online · research-article; journal article · DOI 10.1107/s1600536808023775

Bibliografisk träff 2008-03-13

Integration of in vivo and in vitro approaches to characterize the toxicity of Antalarmin, a corticotropin-releasing hormone receptor antagonist.

Horn TL, Harder JB, Johnson WD, Curry PT, Parchment RE, Morrissey RL, Mellick PW, Calis KA, Gold PW, Rice KC, Contoreggi C, Charney DS, Cizza G, Glaze ER, Tomaszewski JE, McCormick DL.

Toxicology · research support, n.i.h., intramural; research-article; journal article; research support, n.i.h., extramural · DOI 10.1016/j.tox.2008.03.002

Bibliografisk träff 2007-08-20

The CRF1 receptor antagonist antalarmin attenuates yohimbine-induced increases in operant alcohol self-administration and reinstatement of alcohol seeking in rats.

Marinelli PW, Funk D, Juzytsch W, Harding S, Rice KC, Shaham Y, Lê AD.

Psychopharmacology (Berl) · research support, non-u.s. gov't; journal article; research support, n.i.h., extramural · DOI 10.1007/s00213-007-0905-x

Bibliografisk träff 2007-08-01

Treatment with CRH-1 antagonist antalarmin reduces behavioral and endocrine responses to social stressors in marmosets (Callithrix kuhlii).

French JA, Fite JE, Jensen H, Oparowski K, Rukstalis MR, Fix H, Jones B, Maxwell H, Pacer M, Power ML, Schulkin J.

Am J Primatol · research-article; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1002/ajp.20385

Bibliografisk träff 2006-12-19

Effects of the CRF1 antagonist antalarmin on cocaine self-administration and discrimination in rhesus monkeys.

Mello NK, Negus SS, Rice KC, Mendelson JH.

Pharmacol Biochem Behav · research support, n.i.h., intramural; journal article; research support, n.i.h., extramural · DOI 10.1016/j.pbb.2006.11.008

Bibliografisk träff 2006-06-01

The CRF1 receptor antagonist, antalarmin, reverses isolation-induced up-regulation of dopamine D2 receptors in the amygdala and nucleus accumbens of fawn-hooded rats.

Djouma E, Card K, Lodge DJ, Lawrence AJ.

Eur J Neurosci · research support, non-u.s. gov't; journal article · DOI 10.1111/j.1460-9568.2006.04864.x

Bibliografisk träff 2005-02-05

The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats.

Jutkiewicz EM, Wood SK, Houshyar H, Hsin LW, Rice KC, Woods JH.

Psychopharmacology (Berl) · research support, u.s. gov't, p.h.s.; research-article; journal article; research support, n.i.h., extramural · DOI 10.1007/s00213-005-2164-z

Bibliografisk träff 2002-07-01

Effect of antalarmin, a novel corticotropin-releasing hormone antagonist, on the dynamic function of the preterm ovine fetal hypothalamo-pituitary-adrenal axis.

Young IR, Chan EC, Smith R, Chrousos GP, Veldhuis JD, Canny BJ.

Neuroendocrinology · research support, non-u.s. gov't; journal article · DOI 10.1159/000063683

Bibliografisk träff 1999-01-01

The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress.

Deak T, Nguyen KT, Ehrlich AL, Watkins LR, Spencer RL, Maier SF, Licinio J, Wong ML, Chrousos GP, Webster E, Gold PW.

Endocrinology · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1210/endo.140.1.6415

Bibliografisk träff 1996-12-01

In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.

Webster EL, Lewis DB, Torpy DJ, Zachman EK, Rice KC, Chrousos GP.

Endocrinology · journal article · DOI 10.1210/endo.137.12.8940412